SAMSUNG PHARM. Co., LTD. (KRX: 001360)
South Korea
· Delayed Price · Currency is KRW 1,489.00
-11.00 (-0.73%)
Nov 15, 2024, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2013 - 2009 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '19 Sep 30, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | 2013 - 2009 |
| Operating Revenue | 44,654 | 46,484 | 41,919 | 47,194 | 42,165 | 30,288 | Upgrade
|
| Other Revenue | -0 | - | - | 0 | - | 0 | Upgrade
|
| Revenue | 44,654 | 46,484 | 41,919 | 47,194 | 42,165 | 30,288 | Upgrade
|
| Revenue Growth (YoY) | 4.72% | 10.89% | -11.18% | 11.93% | 39.21% | -35.95% | Upgrade
|
| Cost of Revenue | 36,632 | 37,903 | 36,851 | 38,425 | 30,909 | 21,821 | Upgrade
|
| Gross Profit | 8,022 | 8,580 | 5,069 | 8,770 | 11,256 | 8,467 | Upgrade
|
| Selling, General & Admin | 11,544 | 12,228 | 11,708 | 15,001 | 13,703 | 9,033 | Upgrade
|
| Research & Development | 181.34 | 377.51 | 938.79 | 898.61 | 296.67 | 5.83 | Upgrade
|
| Other Operating Expenses | 717.76 | 755.65 | 261.64 | 475.91 | 398.1 | 343.79 | Upgrade
|
| Operating Expenses | 16,789 | 13,980 | 12,843 | 15,096 | 13,127 | 28,287 | Upgrade
|
| Operating Income | -8,767 | -5,399 | -7,774 | -6,327 | -1,870 | -19,820 | Upgrade
|
| Interest Expense | -782.52 | -1,357 | -2,590 | -2,456 | -3,016 | -1,485 | Upgrade
|
| Interest & Investment Income | 926.36 | 1,246 | 692.21 | 323.74 | 116.41 | 10.58 | Upgrade
|
| Currency Exchange Gain (Loss) | 15.11 | -9.87 | -26.54 | 45.02 | 27.8 | -0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,335 | 273.82 | -870.64 | -1,665 | 1,186 | -1,755 | Upgrade
|
| EBT Excluding Unusual Items | -9,943 | -5,246 | -10,569 | -10,079 | -3,557 | -23,050 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4,027 | 3,203 | -117.01 | -3,605 | 3,290 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.82 | 27 | 292.49 | 13.04 | -0.27 | - | Upgrade
|
| Asset Writedown | - | - | -577.53 | -3,067 | -386.94 | -1,000 | Upgrade
|
| Other Unusual Items | 11.3 | - | 5.46 | -609.29 | - | 301.82 | Upgrade
|
| Pretax Income | -5,899 | -2,016 | -10,966 | -17,348 | -653.84 | -23,748 | Upgrade
|
| Income Tax Expense | 59.55 | 59.55 | -3,692 | -129.71 | 340.54 | - | Upgrade
|
| Earnings From Continuing Operations | -5,959 | -2,076 | -7,274 | -17,218 | -994.39 | -23,748 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -265.93 | -4,400 | - | - | Upgrade
|
| Net Income to Company | -5,959 | -2,076 | -7,540 | -21,618 | -994.39 | -23,748 | Upgrade
|
| Minority Interest in Earnings | - | - | -0 | 0 | 0.01 | - | Upgrade
|
| Net Income | -5,959 | -2,076 | -7,540 | -21,618 | -994.38 | -23,748 | Upgrade
|
| Net Income to Common | -5,959 | -2,076 | -7,540 | -21,618 | -994.38 | -23,748 | Upgrade
|
| Shares Outstanding (Basic) | 58 | 51 | 40 | 33 | 25 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 51 | 40 | 33 | 25 | 18 | Upgrade
|
| Shares Change (YoY) | 24.91% | 28.44% | 21.80% | 28.46% | 40.00% | 126.18% | Upgrade
|
| EPS (Basic) | -101.96 | -40.51 | -189.00 | -660.00 | -39.00 | -1304.00 | Upgrade
|
| EPS (Diluted) | -101.96 | -40.51 | -189.00 | -660.00 | -39.00 | -1304.00 | Upgrade
|
| Free Cash Flow | -14,727 | -9,134 | -956.01 | -43,177 | -16,067 | -15,674 | Upgrade
|
| Free Cash Flow Per Share | -252.00 | -178.27 | -23.96 | -1318.23 | -630.15 | -860.64 | Upgrade
|
| Gross Margin | 17.96% | 18.46% | 12.09% | 18.58% | 26.70% | 27.96% | Upgrade
|
| Operating Margin | -19.63% | -11.62% | -18.55% | -13.41% | -4.44% | -65.44% | Upgrade
|
| Profit Margin | -13.34% | -4.47% | -17.99% | -45.81% | -2.36% | -78.41% | Upgrade
|
| Free Cash Flow Margin | -32.98% | -19.65% | -2.28% | -91.49% | -38.11% | -51.75% | Upgrade
|
| EBITDA | -4,675 | -1,635 | -3,859 | -2,060 | 608.49 | -18,347 | Upgrade
|
| EBITDA Margin | -10.47% | -3.52% | -9.21% | -4.36% | 1.44% | -60.57% | Upgrade
|
| D&A For EBITDA | 4,092 | 3,764 | 3,915 | 4,267 | 2,479 | 1,473 | Upgrade
|
| EBIT | -8,767 | -5,399 | -7,774 | -6,327 | -1,870 | -19,820 | Upgrade
|
| EBIT Margin | -19.63% | -11.62% | -18.55% | -13.41% | -4.44% | -65.44% | Upgrade
|
| Advertising Expenses | - | 921.87 | 150.94 | 975.62 | 1,202 | 55.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.